Bio-link Australia Pty. Ltd.


Please find below a list of selected recent news and press releases from Bio-Link, our clients and the industry. Please select a specific news list for each source from the buttons on the left hand side.

31st January 2017 – Bio-Link Engaged by Neural Diagnostics

Bio-Link has been engaged by Neural Diagnostics for the development of ElectroVestibuloGraphy (EVestG™), a novel medical device for the classification of neurological diseases to ensure that patients are in need of neurosurgery or not. Bio-Link is seeking commercial partner(s) for licensing and commercial development of EVestG™ in the fields of clinical diagnostics, medical devices and drug development for the proper treatment that is required to battle such harmful neurological diseases that affect the brain in many ways. There are currently no licensing and partnership opportunities for diagnostic technologies and medical devices. Please see our Therapeutics section for available opportunities.

To learn more about this partnering opportunity, please click here.

Neural Diagnostics

29th August 2016 – Bio-Link Engaged by ShenQi Pharmaceutical

Bio-Link has been engaged by ShenQi Pharmaceutical (ShenQi), a subsidiary of ShenQi Group (GuiZhou, China), to scout for a strategic partner able to contribute advanced assisted reproductive technologies to a new business opportunity in the Chinese market.

To learn more about this partnering opportunity, please click here.


29th August 2016 – Oncology Venture – First metastatic breast cancer patient with LiPlaCis™ confirmed partial response

Oncology Venture has announced that the first patient with metastatic breast cancer included in its LiPlaCis™ extension – proof of concept trial has obtained a confirmed Partial Remission (ie >30% tumour reduction) (press release link). The patient is the first of 12-15 patients whose tumour tissue has been pre-screened as a highly likely responder by Oncology Venture’s Drug Response Predictor (DRP™). Bio-Link is seeking partners to co-develop or secure rights to LiPlaCis™. Click here for full press release.

oncology venture logo-1

28th July 2016 – “Realising Value from Biotechnology” – Bio-Link Published in Australasian Biotechnology

Bio-Link Executive Directors Christopher Boyer and Dr Christian Toouli have written an article for the recently published July addition of “Australasian Biotechnology” (volume 26, number 2). The article focuses on the need for biotechnology innovators to prioritise commercialisation, and in particular partnering, to realise maximum value from their assets. Please click here to read the article.

25th July 2016 – Bio-Link Australia to Offer Patsnap Global Patent Database and IP Analytics Software

Bio-Link has secured a license to PatSnap’s Global Patent Database and IP Analytics Software, enabling Bio-Link to offer a tailored patent analytics service to its biopharmaceutical, medical device and academic clients. Click here for full press release.

Patsnap IP